Skip to search formSkip to main contentSkip to account menu

Myasthenia Gravis, Autoimmune, Experimental

Known as: Experimental Myasthenias, Experimental Myasthenia, Myasthenia Gravis, Autoimmune Experimental 
Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
For Exp. 1, one hundred twenty Duroc×Yorkshire×Landrace pigs (6.34±0.70 kg average initial BW) were used in a 35 d growth assay… 
Highly Cited
1999
Highly Cited
1999
IFN-gamma can either adversely or beneficially affect certain experimental autoimmune diseases. To study the role of IFN-gamma in… 
1998
1998
Myasthenia gravis is an autoimmune disorder characterized by muscle weakness, due to an antibody-mediated deficit of… 
Highly Cited
1994
Highly Cited
1994
Oral administration of nicotinic acetylcholine receptor (AChR) to Lewis rats prior to myasthenogenic immunization with Torpedo… 
Highly Cited
1991
Highly Cited
1991
A synthetic gene encoding the 210 N-terminal residues of the alpha-subunit of the nicotinic acetylcholine receptor (AChR) of… 
1991
1991
A single immunization of Lewis rats with purified acetylcholine receptor (AChR) emulsified in adjuvant typically stimulates the… 
1984
1984
Experimental autoimmune myasthenia gravis (EAMG) is an autoimmune disease in which antibodies to acetylcholine receptor (AChR… 
Highly Cited
1982
Highly Cited
1982
Aberrations in immune function that ultimately result in disease states may involve three aspects of immune regulation: (1…